[Present status of high-dose intravenous immunoglobulin therapy and the future prospects ].
Kawasugi
Kazuo
K
D020275:Guillain-Barre Syndrome / Q000188:drug therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000188:drug therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy; D011961:Receptors, Fc / Q000037:antagonists & inhibitors
D016756:Immunoglobulins, Intravenous; D011961:Receptors, Fc